Article Text

Download PDFPDF
Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation
  1. Hisashi Moriguchi1,
  2. Joren Madson2
  1. 1Reprogramming Inc, Chiba, Japan
  2. 2Reprogramming Inc, Boston, Massachusetts, USA
  1. Correspondence to Dr Hisashi Moriguchi, moriguchi-tky{at}


Temporarily withdrawn while we investigate a complaint.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.